We are live on ! Find out more
CLLS

Cellectis

79 hedge funds and large institutions have $247M invested in Cellectis in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

85% more capital invested

Capital invested by funds: $133M → $247M (+$114M)

20% more funds holding

Funds holding: 6679 (+13)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

1.26% less ownership

Funds ownership: 34.03%32.77% (-1.3%)

Holders
79
Holders Change
+13
Holders Change %
+19.7%
% of All Funds
1.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
22
Reduced
24
Closed
12
Calls
$285K
Puts
Net Calls
+$285K
Net Calls Change
-$51K
Name Holding Trade Value Shares
Change
Change in
Stake
Daiwa Securities Group
76
Daiwa Securities Group
Japan
$1K
VFA
77
Valeo Financial Advisors
Indiana
$1K +$30 +2 +3%
TI
78
tru Independence
Oregon
$8 +$2.22K +146 +48%
IG
79
ING Group
Netherlands
-$1.78M -193,615 Closed
AI
80
Atria Investments
North Carolina
-$212K -22,998 Closed
Goldman Sachs
81
Goldman Sachs
New York
-$182K -19,828 Closed
WCA
82
Windsor Creek Advisors
Vermont
-$101K -11,004 Closed
EGM
83
Engineers Gate Manager
New York
-$101K -11,000 Closed
GPCM
84
Granite Point Capital Management
Massachusetts
-$92K -10,000 Closed
NG
85
NWK Group
California
-$12K -1,350 Closed
FGAM
86
Financial Gravity Asset Management
Texas
-$11.5K -1,254 Closed
S
87
SignatureFD
Georgia
-$3K -313 Closed

CLLS Hedge Fund Activity: Q2 2020 in Review

79 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2020, worth a combined $247M — up 85% from $133M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new CLLS positions and 12 closed out — a net gain of 13 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $18.7M. The largest seller was Fidelity Investments, cutting an estimated $20.4M.

  • 79 institutional investors held Cellectis (CLLS) as of Q2 2020, up from 66 in Q1 2020.
  • Funds reported $247M of Cellectis stock for Q2 2020, up 85% quarter-over-quarter.
  • 25 funds opened new Cellectis positions in Q2 2020 and 12 closed out, a net change of +13 holders.
  • The largest Cellectis buyer in Q2 2020 was ARK Investment Management, an estimated $18.7M added.
  • The largest Cellectis seller in Q2 2020 was Fidelity Investments, an estimated $20.4M sold.

Based on aggregated 13F filings for Q2 2020.